Fordyce Marshall
Vera Therapeutics, Inc. · PRESIDENT AND CEO
Fordyce Marshall serves as the President and CEO of Vera Therapeutics, Inc., a company focused on developing innovative therapies for patients with serious autoimmune diseases. His recent insider trading activity is highlighted by multiple sales of shares in Vera Therapeutics, reflecting a concentrated pattern of divestment. Between May 13, 2026, and July 9, 2026, Marshall reported six transactions consisting solely of sales, with the largest move occurring on July 9, 2026, amounting to approximately $1.37 million.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $521k14.2k shares | SellMay 12, 2026 | $36.64 | $39.12 | |
| $159k4.3k shares | SellMay 12, 2026 | $37.09 | $39.12 |